Internal Medicine, Hematology & Oncology · Canfield, OH
NPI
1689806705
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3695a Boardman Canfield Rd
Canfield, OH, 44406
Phone (330) 533-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
59,832 services
Medicare patients, 2024
336
Average age 74
Drug cost, 2024
$3.0M
796 prescriptions
Company payments, 2025
$4,207
From 57 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vaibhav Verma was code 36415 (venipuncture blood collection), 442 times for 128 patients. In total Vaibhav Verma billed 59,832 services in 80 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 442 | 128 | $8.63 | $3,815 |
| 85025 Blood Count | Office | 432 | 124 | $7.61 | $3,288 |
| 99213 Office E&M - Established | Office | 282 | 117 | $63.09 | $18K |
| 80053 Clinical Chemistry | Office | 268 | 94 | $10.35 | $2,774 |
| 99232 Hospital E&M - Subsequent | Facility | 241 | 123 | $59.10 | $14K |
| 96375 Injection Administration | Office | 167 | 14 | $11.15 | $1,863 |
| 99222 Hospital E&M - Initial | Facility | 148 | 130 | $98.10 | $15K |
| 99214 Office E&M - Established | Office | 126 | 39 | $92.60 | $12K |
| 96413 Chemotherapy Administration | Office | 123 | 12 | $90.65 | $11K |
| 84466 Clinical Chemistry | Office | 87 | 58 | $12.50 | $1,088 |
| 82728 Clinical Chemistry | Office | 87 | 58 | $13.36 | $1,162 |
| 83540 Clinical Chemistry | Office | 87 | 58 | $6.34 | $552 |
| 96372 Injection Administration | Office | 65 | 13 | $10.44 | $678 |
| 84443 Clinical Chemistry | Office | 60 | 13 | $16.46 | $988 |
| 99204 Office E&M - New | Office | 55 | 55 | $125.36 | $6,895 |
By year: 2022 $339K for 22,326 services; 2023 $332K for 22,308 services; 2024 $1.1M for 59,832 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 442 | 128 | $8.63 | $3,815 |
| 85025 Blood Count | 432 | 124 | $7.61 | $3,288 |
| 80053 Clinical Chemistry | 268 | 94 | $10.35 | $2,774 |
| 84466 Clinical Chemistry | 87 | 58 | $12.50 | $1,088 |
| 83540 Clinical Chemistry | 87 | 58 | $6.34 | $552 |
| 82728 Clinical Chemistry | 87 | 58 | $13.36 | $1,162 |
| 84443 Clinical Chemistry | 60 | 13 | $16.46 | $988 |
| 82784 Immunoassay | 42 | 13 | $9.11 | $383 |
| 83883 Clinical Chemistry | 42 | 20 | $13.33 | $560 |
| 82607 Clinical Chemistry | 39 | 31 | $14.78 | $576 |
Medicare prescription drug claims, 2024
In 2024, the drug Vaibhav Verma prescribed most often to Medicare patients was Eliquis (Apixaban), with 85 prescriptions and refills. In total Vaibhav Verma wrote 796 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 85 | 112 | 17 | $63K |
| Ondansetron Odt Ondansetron | 51 | 51 | 37 | $715 |
| Acyclovir Generic | 33 | 37 | 12 | $524 |
| Levofloxacin Generic | 30 | 30 | 12 | $105 |
| Neulasta Onpro Pegfilgrastim | 27 | 27 | Under 11 | $164K |
| Bortezomib Generic | 27 | 27 | Under 11 | $5,908 |
| Zirabev Bevacizumab-Bvzr | 26 | 26 | Under 11 | $105K |
| Xgeva Denosumab | 25 | 27 | Under 11 | $80K |
| Kisqali Ribociclib Succinate | 23 | 23 | Under 11 | $402K |
| Anastrozole Generic | 23 | 64 | Under 11 | $404 |
| Azacitidine Generic | 20 | 20 | Under 11 | $69K |
| Aranesp Darbepoetin Alfa In Polysorbat | 20 | 20 | Under 11 | $6,896 |
| Libtayo Cemiplimab-Rwlc | 18 | 18 | Under 11 | $187K |
| Prednisone Generic | 18 | 19 | Under 11 | $81.14 |
| Xarelto Rivaroxaban | 17 | 24 | Under 11 | $13K |
Brand drugs: 454 claims; generic drugs: - claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vaibhav Verma $4,207 ($4,207 in general payments such as food, travel and fees) from 57 companies. The largest payer was Abbvie Inc. with $362.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 19 | $362 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $302 |
| Merck Sharp & Dohme LLC MRK | 12 | $302 |
| Daiichi Sankyo Inc. 4568.T | 15 | $261 |
| Genentech USA, Inc. ROG.SW | 11 | $165 |
| Exelixis Inc. EXEL | 2 | $147 |
| Syndax Pharmaceuticals, Inc. SNDX | 2 | $142 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $140 |
| Celgene Corporation BMY | 10 | $138 |
| Pfizer Inc. PFE | 8 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.